Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Paraquat Jury Trial Over Parkinson’s Risk Set To Begin Oct. 16, 2023 in Federal MDL After an aggressive pretrial schedule was set to get the first Paraquat Parkinson’s lawsuit before a jury, the Court has pushed back jury selection several times during the litigation due to various factors, including the pandemic, hurricanes and problems coordinating with state courts. December 16, 2022 Irvin Jackson Add Your Comments Paraquat is a widely used weedkiller, which has been linked to a Parkinson’s risk Although all safety precautions and warnings were followed, plaintiffs claim they were left with Parkinson’s after spraying, mixing, handling or being in the area where the weedkiller was applied Series of early Paraquat jury trials originally expected to begin in November 2022, are now set for October 2023 Outcome may have an impact on Paraquat Parkinson’s settlements offered in the future LEARN MORE ABOUT PARAQUAT PARKINSON’S RISK The U.S. District Judge presiding over all Paraquat lawsuits has pushed back the start of the first federal jury trial until October 2023, indicating that a number of uncontrollable circumstances have resulted in the need for a further delay in the aggressive pretrial schedule, which was originally expected to see the first claim over Parkinson’s disease caused by the controversial weedkiller go before a jury in November 2022. There are currently more than 2,000 product liability cases filed against Syngenta and Chevron in the federal courts, each raising similar allegations that the companies failed to warn farmers and agricultural users about the Paraquat Parkinson’s risks, which research has found may develop after regularly spraying, mixing, transporting or handling the weed killer, even when all recommended safety precautions are followed. Given common questions of fact and law raised in the litigation, the federal cases have been centralized as part of a Paraquat MDL (multi-district litigation) since June 2021, which is consolidated before U.S. District Judge Nancy J. Rosenstengel in the Southern District of Illinois, for coordinated discovery and pretrial proceedings. PARAQUAT Parkinson’s Lawsuits Were you or a loved one exposed to Paraquat? Lawyers are reviewing Paraquat lawsuits for individuals who were exposed to Paraquat and developed Parkinson’s disease. Learn More SEE IF YOU QUALIFY FOR COMPENSATION PARAQUAT Parkinson’s Lawsuits Were you or a loved one exposed to Paraquat? Lawyers are reviewing Paraquat lawsuits for individuals who were exposed to Paraquat and developed Parkinson’s disease. Learn More SEE IF YOU QUALIFY FOR COMPENSATION To help the parties evaluate how juries may respond to certain evidence and testimony that will be presented throughout various claims, the Court previously set an aggressive schedule early in the litigation, which called for the first Paraquat Parkinson’s jury trial to begin in November 2022. However, as a growing number of claims continue to be filed, the start of that first bellwether trial has been pushed back to the middle of next year, and it has now been delayed again. New Paraquat Bellwether Trial Date Set On December 12, Judge Rosenstengel issued a case management order (PDF) which reschedules the first Paraquat jury trial to begin on October 16, 2023. In the order, the Court points to a number of factors that have led to delays, between the pandemic, illnesses, hurricanes and other unexpected problems. “The undersigned started this litigation in June 2021 with an aggressive schedule, with the goal of having the first trial underway in November 2022,” Judge Rosenstengel said in the order. “At that time the Court (regrettably) did not anticipate the resistance that would come from efforts to coordinate with local state court litigation which had recently settled on the eve of trial after extended pretrial proceedings.” Jury selection is now scheduled to begin on October 16, 2023, following a final pretrial conference that will be held on October 3. The new order also calls for Defendants to provide Plaintiffs with a list of experts and dates for expert depositions by December 23 and depositions of Plaintiffs’ experts must be complete by January 6, 2023. Summary judgment and Daubert motions will be filed by April 17, 2023, according to the new schedule, with a hearing on those motions due by June 26, 2023. The original trial date of November 2022 was to be followed by additional bellwether trial dates in March, July and September of 2023. However, those trial dates have been vacated, and it is unclear when they will be rescheduled. December 2022 Paraquat Settlement Update To help promote Paraquat settlement talks and avoid the need for each individual case to go to trial, Judge Rosenstengal ordered the parties to conduct case-specific discovery in a group of 20 additional lawsuits earlier this year. These are not currently part of the initial bellwether jury trial pool, but are believed to be typical of Paraquat cases likely to go before juries in the future if a settlement is not reached, and may be among the first remanded back to U.S. District Courts nationwide for individual trials if the Paraquat MDL is not resolved. The cases were selected in August 2022, and deadlines were established for the parties to complete depositions in most of the cases this week. However, the parties conferred with the Special Master assigned to the litigation, and requested additional time to complete the discovery. While the outcome of the early Paraquat jury trials and case-specific discovery in non-bellwether claims will not have any binding impact on other plaintiffs, they are expected to greatly influence the average Paraquat settlement amounts the manufacturers may offer to avoid each individual claim being remanded back to U.S. District Courts nationwide for separate trial dates in the coming years. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Chevron, Herbicide, Paraquat, Parkinsons Disease, Syngenta, Weed Killer More Paraquat Lawsuit Stories Paraquat MDL Lawsuit Deadlines Extended Again, as Settlement Details Finalized August 12, 2025 Paraquat Parkinson’s Disease Settlement Terms Still Being Finalized June 30, 2025 MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 May 16, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (Posted: today) Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)Pfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025) Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (Posted: yesterday) A Texas mother is pursuing a lawsuit against Roblox and Discord, claiming the design of the apps allow sexual predators to access and groom young children. MORE ABOUT: ROBLOX LAWSUITLawsuit Alleges Roblox Lacks Safeguards To Protect Children From Sexual Predators (09/11/2025)Roblox Age Verification Technology To Be Implemented Amid Child Exploitation Lawsuits (09/09/2025)Roblox Kidnapping Lawsuit Filed After Child Was Abducted and Sexually Trafficked (09/03/2025) Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (Posted: 2 days ago) Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer. MORE ABOUT: DUPIXENT LAWSUITDupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (Posted: today) Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)Pfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)
Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (Posted: yesterday) A Texas mother is pursuing a lawsuit against Roblox and Discord, claiming the design of the apps allow sexual predators to access and groom young children. MORE ABOUT: ROBLOX LAWSUITLawsuit Alleges Roblox Lacks Safeguards To Protect Children From Sexual Predators (09/11/2025)Roblox Age Verification Technology To Be Implemented Amid Child Exploitation Lawsuits (09/09/2025)Roblox Kidnapping Lawsuit Filed After Child Was Abducted and Sexually Trafficked (09/03/2025)
Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (Posted: 2 days ago) Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer. MORE ABOUT: DUPIXENT LAWSUITDupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)